Pesticide News Story: Scientific Advisory Panel will Meet April 26 - 29, 2010 to Continue Review of Atrazine Health Effects
For Release: March 10, 2010
The FIFRA Scientific Advisory Panel (SAP) is scheduled to meet on April 26 - 29, 2010 to review a set of scientific issues related to EPA’s reevaluation of the human health effects of the pesticide atrazine. Although the April SAP meeting was originally planned to be held earlier in the month, the meeting dates were changed to address scheduling issues. The April meeting will focus on a preliminary review of mammalian in vivo and in vitro studies on toxicological effects and modes of action, and on statistical approaches for evaluating monitoring frequency in community water systems.
The meeting will be held at the Hamilton Crowne Plaza Hotel, located at 1001 14th Street, N.W., Washington, DC 20005, telephone number (202) 682-0111. The meeting will begin on Monday, April 26 at 1 p.m. On April 27-29, the meeting will be held from approximately 8:30 a.m. to 5 p.m.
Interested parties are invited to participate in this SAP meeting by submitting written or oral comments. The Agency encourages that written comments be submitted by April 12, 2010, and requests for oral comments be submitted by April 19, 2010.
The FIFRA SAP is soliciting the stakeholder community for nominations of prospective candidates to serve as ad hoc members of the panel for this meeting. In order to have the collective breadth of experience needed to address the Agency’s charge for this meeting, the Agency anticipates selecting approximately 15 ad hoc scientists. Nominations are due March 19, 2010. The panel for the April meeting will also include permanent SAP members.
For further information about how to participate, please see EPA’s March 5, 2010 Federal Register notice, available in docket EPA-HQ-OPP-2010-0125 at www.regulations.gov. EPA’s 2010 SAP Meetings Web page, also provides detailed information about each SAP meeting. The Atrazine Updates Web page, provides information about the Agency’s reevaluation of the human health effects of atrazine.